Ekso Bionics (Nasdaq: EKSO), manufacturer of the Ekso Indego Personal exoskeleton, reported lower revenue numbers for its second quarter in a July 28 earnings call. “While there was abnormal weakness in the second quarter, in large part due to what we believe are short-term delays in completing some multi-device enterprise health sales, we are working…
Ekso Bionics ‘Working to Get Back on Track’ After Lower Second-Quarter Earnings Report
Commentary: Once Again, Wheelchairs Considered Second-Class Solutions
Medicare is now funding personal exoskeletons. But what’s so wrong about rolling?
In April, the Centers for Medicare & Medicaid Services (CMS) announced Medicare coverage for personal exoskeletons. ReWalk (DBA: Lifeward), an exoskeleton manufacturer, praised the decision: “The Centers for Medicare & Medicaid Services has officially revised its April 2024 Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule to include a final lump-sum Medicare purchase…
ReWalk Robotics Lauds Medicare Allowable for Personal Exoskeletons
The final payment rate affects claims with dates of service on or after April 1.
ReWalk Robotics Ltd. (DBA: Lifeward) is lauding the Centers for Medicare & Medicaid Services’ (CMS) decision to provide Medicare coverage for personal exoskeletons. In an April 12 announcement, ReWalk — which manufactures the ReWalk personal exoskeleton and the ReStore Exo-Suit, among other rehabilitation products — said, “The Centers for Medicare & Medicaid Services has officially…